Search Results

Confo Therapeutics today announced that it has entered into a collaborative agreement with Regeneron Pharmaceuticals

Switzerland, December 17, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical

inactive conformation using molecular dynamic simulations "The δ-opioid receptor (DOR) is a critical pharmaceutical

Switzerland, July 22, 2022 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical

given the Society’s conference will be held in Perth next year, in collaboration with the Australasian Pharmaceutical

However, AlphaFold3 faces challenges with synthetic ligands, which are central to pharmaceutical development

Apprentice Head of Human Resource Business Partners Senior Scientist, In vitro pharmacology - Crinetics Pharmaceuticals Senior Director, In vitro pharmacology - Crinetics Pharmaceuticals Explore Dr.

Advances in GPCRs: Structure, Mechanisms, Disease, and Pharmacology Industry News Monash University pharmaceutical Data on DT-9045, a First-in-class Negative Allosteric Modulator of PAR2 for Immuno-oncology Crinetics Pharmaceuticals

2011, she had established her own group within the Drug Discovery Biology theme at Monash Institute of Pharmaceutical

In recent years, pharmaceutical companies have begun to utilize cryo-EM for structure-based drug design

Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults Crinetics Pharmaceuticals Update Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024 Crinetics Pharmaceuticals

Expertise in Oncology Octant Bio will be at the Goldman Sachs Global Healthcare Conference Crinetics Pharmaceuticals

But at Monash Institute of Pharmaceutical Sciences, a different idea took root: what if collaboration

not only deepens our understanding of a key biological process but also provides a valuable map for pharmaceutical

Poon to Board of Directors Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing

By identifying key β2AR residues that influence efficacy and potency, pharmaceutical researchers can

Industry News X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market Andrew

She entered undergrad set on becoming a pharmacist. kind of had an identity crisis because I think I realized in that moment that I didn't want to be a pharmacist

develop new therapies for people living with obesity, diabetes and other serious metabolic diseases X4 Pharmaceuticals

Voyager’s GBA1 Program and Other Next-Generation Gene Therapies for Neurological Diseases Crinetics Pharmaceuticals

Nordisk looks to next generation of obesity, diabetes drugs with $550M Replicate research deal; Rhythm Pharmaceuticals

exclusively to our Premium Members this week: Industry insights:  Discover the latest strategic moves in the pharmaceutical

all symptoms of schizophrenia Sosei Heptares to receive US$2.5 million milestone payment from Formosa Pharmaceuticals

Structural analysis of the human C5a-C5aR1 complex using cryo-electron microscopy Industry News Crinetics Pharmaceuticals

in nearly all physiological systems make GPCR the largest protein family targeted for development of pharmaceuticals

📰 GPCR Weekly News, July 22 to 28, 2024 In the fast-paced world of pharmaceuticals and drug discovery

spinning GPR68 small molecules into GIO New treatments being developed for schizophrenia Crinetics Pharmaceuticals

Jack Antel to its clinical advisory board Crinetics Pharmaceuticals First Quarter 2023 Earnings: Revenues

Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating

amended deal with Gilead on anti-CCR8 antibody InterAx Biotech Announces the Appointment of Seasoned Pharmaceutical